Treatment effectiveness for genital ulcer syndrome and genital discharge syndrome based on a survey of STD/RTI patients who did not return for follow up*
| Men | Women | |||||||
|---|---|---|---|---|---|---|---|---|
| GUS | UDS | GUS | VDS | |||||
| GUS = genital ulcer syndrome, UDS = urethral discharge syndrome, VDS = vaginal discharge syndrome. | ||||||||
| *Information obtained through home visits of patients 2 weeks to 3 months after treatment. | ||||||||
| †One woman with GUS and six women with VDS had signs on examination although they reported that they were free of symptoms. | ||||||||
| Number of study participants | 64 | 89 | 42 | 97 | ||||
| Treatment outcome reported by patients: | ||||||||
| No symptoms (=cured and no recurrence) | 52 | 81% | 62 | 69% | 22 | 52% | 51 | 53% |
| Symptoms reported: | ||||||||
| Re-infection or recurrence of symptoms | 9 | 14% | 20 | 23% | 11 | 26% | 34 | 35% |
| Not cured | 3 | 5% | 7 | 8% | 9 | 21% | 12 | 12% |
| Signs observed by clinician on examination†| 12 | 19% | 22 | 25% | 21 | 50% | 52 | 54% |